T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Mirum Pharmaceuticals
MIRM
$3.74B
| $50.1M | 0.01% |
1,284,106
+84,886
| +7% | +$3.31M |
|
|
CRGX
752
DELISTED
CARGO Therapeutics
CRGX
| $49.7M | 0.01% |
2,694,306
-483,765
| -15% | -$8.93M |
|
753
Aaon
AAON
$6.87B
| $49.6M | 0.01% |
460,061
-22,275
| -5% | -$2.4M |
|
754
Regions Financial
RF
$24.1B
| $49.6M | 0.01% |
2,126,043
+21,946
| +1% | +$512K |
|
755
Lincoln Electric
LECO
$13.5B
| $49.5M | 0.01% |
257,562
+1,961
| +0.8% | +$377K |
|
756
eBay
EBAY
$42.5B
| $49.5M | 0.01% |
759,474
+46,342
| +6% | +$3.02M |
|
757
McCormick & Company Non-Voting
MKC
$18.7B
| $49.3M | 0.01% |
598,556
-122
| -0% | -$10K |
|
758
Watsco
WSO
$16.1B
| $49.2M | 0.01% |
99,931
-29,737
| -23% | -$14.6M |
|
759
Exelixis
EXEL
$10.3B
| $49.1M | 0.01% |
1,891,847
-58,021
| -3% | -$1.51M |
|
760
Installed Building Products
IBP
$7.42B
| $49.1M | 0.01% |
199,225
-5,463
| -3% | -$1.35M |
|
761
Occidental Petroleum
OXY
$45.4B
| $48.9M | 0.01% |
949,285
+14,825
| +2% | +$764K |
|
762
Entrada Therapeutics
TRDA
$200M
| $48.7M | 0.01% |
3,049,572
-84,886
| -3% | -$1.36M |
|
763
CRH
CRH
$76B
| $48.4M | 0.01% |
521,919
+5,446
| +1% | +$505K |
|
764
Enphase Energy
ENPH
$5.03B
| $48M | 0.01% |
425,073
+130,976
| +45% | +$14.8M |
|
765
The Bancorp
TBBK
$3.55B
| $48M | 0.01% |
897,527
+226
| +0% | +$12.1K |
|
766
Patrick Industries
PATK
$3.79B
| $47.5M | 0.01% |
500,823
-785
| -0.2% | -$74.5K |
|
767
WEC Energy
WEC
$35.4B
| $47.4M | 0.01% |
492,295
+1,296
| +0.3% | +$125K |
|
768
Insulet
PODD
$24B
| $47M | 0.01% |
201,984
-205,677
| -50% | -$47.9M |
|
769
Edison International
EIX
$21.5B
| $47M | 0.01% |
539,771
-6,145
| -1% | -$535K |
|
770
VanEck Oil Services ETF
OIH
$865M
| $47M | 0.01% |
165,584
+5,707
| +4% | +$1.62M |
|
771
BioMarin Pharmaceuticals
BMRN
$10.5B
| $46.6M | 0.01% |
663,555
-319,785
| -33% | -$22.5M |
|
772
ACI Worldwide
ACIW
$5.16B
| $46.2M | 0.01% |
908,101
-3,332
| -0.4% | -$170K |
|
773
T. Rowe Price Growth Stock ETF
TGRW
$880M
| $46.1M | 0.01% |
1,225,001
+575,000
| +88% | +$21.7M |
|
774
T. Rowe Price Dividend Growth ETF
TDVG
$1.08B
| $46.1M | 0.01% |
1,125,001
+475,000
| +73% | +$19.5M |
|
775
Transmedics
TMDX
$4.01B
| $46.1M | 0.01% |
293,466
-36,968
| -11% | -$5.8M |
|